Patrick C.H. Alcohol, Culture, and Society. Durham, NC: Duke University Press. 1952. Р. 12–13.
Savolainen V.T., Liesto K. M nnikk A. et al. Alcohol consumption and alcoholic liver disease: Evidence of a threshold level of effects of ethanol // Alcohol. Clin. Exp. Res. 1993. №17(5). Р. 1112–1117.
Lelbach W.K. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse // Ann. N.Y. Acad. Sci. 1975. №252. Р. 85–105.
Grant B.F., Dufour M.C., Harford T.C. Epidemiology of alcoholic liver disease // Semin. Liver. Dis. 1988. №8(1). Р. 12–25.
Crabb D.W. Pathogenesis of alcoholic liver disease: newer mechanisms of injury // Keio. J. Med. 1999. №48. Р. 184–188.
Lieber C.S., Jones D.P., Decarli L.M. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets // J. Clin. Invest. 1965. №44. Р. 1009–1021.
Mendenhall C.L. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis // Am. J. Dig. Dis. 1968. №13. Р. 783–791.
Leevy C.M. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature // Medicine (Baltimore). 1962. №41. Р. 249–276.
Sorensen T.I., Orholm M., Bentsen K.D., Hoybye G., Eghoje K., Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis // Lancet. 1984. №2. Р. 241–244.
NIAAA. Eighth Report to the U.S. Congress on Alcohol and Health, 1994.
Maddrey W.C. Alcoholic hepatitis: Clinicopathologic features and therapy // Semin. Liv. Dis. 1998. №8(1). Р. 91–102.
O’Shea R.S., Dasarathy S., McCullough A.J. Alcoholic Liver Disease // Hepatology. 2010. №51(1). Р. 307–328.
Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине // СПб.: Издательский дом «Нева», 2002.
Голдынкина Е.А. Гиссенский опросник давления соматических жалоб / Е.А. Голдынкина, Г.Л. Исурина. СПб.: Психоневрологический институт им. В.М. Бехтерева. 1992.
Pharmacotherapy for alcohol dependence. Summary, Evidence Report / Technology Assessment. 1999. №3. Jan. Agency for Health Care Policy and Research. Rockville, MD.
Srisurapanont M., Jarusuraisin N. Opioid antagonists for alcohol dependence // Cochrane Database Syst. Rev. 2005. CD001867.
Palmer A.J., Neeser K., Weiss C., Brandt A., Comte S., Fox M. The longterm cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate // Alcohol. 2000. №35. Р. 478–492.
Mason B.J. Acamprosate in the treatment of alcohol dependence // Expert Opin. Pharmacother 2005. №6. Р. 2103–2115.
Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003-2017.
Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007;370:1915-1922.
Mezey E. Interaction between alcohol and nutrition in the pathogenesis of alcoholic liver disease. Semin Liver Dis 1991;11:340-348.
Mendenhall CL, Tosch T, Weesner RE, et al: VA cooperative study on alcoholic hepatitis II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986;43:213-218.
Mendenhall CL, Tosch T, Weesner RE, et al: VA cooperative study on alcoholic hepatitis II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986;43:213-218.
Schenker S, Halff GA: Nutritional therapy in alcoholic liver disease. Semin Liver Dis 1993;13(2):196-209.
Carithers RL, Herlong HF, Diehl AM, et al: Methylprednisolone therapy in patients with severe alcoholic hepatitis. Ann Intern Med 1989;110:685-690.
Ramond MJ, Poynard T, Rueff B, et al: A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512.
Depew W, Boyer T, Omata M, et al: Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterol 1980;78(3):524-529.
Theodossi A, Eddleston ALWF, Williams R: Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982; 23(1):75-79.
O'Shea RS, Dasarathy S, McCullough AJ: Alcoholic Liver Disease. Hepatology 2010;51(1):307-328.
O'Shea RS, Dasarathy S, McCullough AJ: Alcoholic Liver Disease. Hepatology 2010;51(1):307-328.
Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119: 1637-1648.
Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, et al. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004;99:255-260.
Burra P, Lucey MR. Liver transplantation in alcoholic patients. Transpl Int 2005;18:491-498.
O’Grady JG. Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet’s nest! Gut 2006;55:1529-1531.
Aertgeerts B. Buntinx F, Kester A: The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol 2004;57:30-39.